Marshall Wace North America’s Innoviva INVA Stock Holding History

Marshall Wace North America’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-33,585	Closed	-$451K	–	1575
2021 Q2	$451K	Buy	+33,585	New	+$420K	﹤0.01%	1195
2020 Q4	–	Sell	-11,280	Closed	-$118K	–	1428
2020 Q3	$118K	Sell	11,280 -24,413	-68%	-$310K	﹤0.01%	1156
2020 Q2	$498K	Buy	+35,693	New	+$486K	﹤0.01%	925
2019 Q4	–	Sell	-8,930	Closed	-$94K	–	1432
2019 Q3	$94K	Sell	8,930 -45,452	-84%	-$544K	﹤0.01%	1069
2019 Q2	$792K	Buy	54,382 +19,503	+56%	+$276K	﹤0.01%	808
2019 Q1	$490K	Buy	+34,879	New	+$565K	﹤0.01%	813
2018 Q1	–	Sell	-75,839	Closed	-$1.08M	–	1555
2017 Q4	$1.08M	Buy	+75,839	New	+$1.01M	0.01%	977
2017 Q3	–	Sell	-822,356	Closed	-$10.7M	–	1384
2017 Q2	$10.7M	Buy	822,356 +798,146	+3,297%	+$10M	0.08%	301
2017 Q1	$339K	Buy	+24,210	New	+$285K	﹤0.01%	858
2013 Q4	–	Sell	-24,487	Closed	-$807K	–	766
2013 Q3	$807K	Buy	+24,487	New	+$761K	0.02%	379

Other funds holding INVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Marshall Wace North America's INVA Position: Q3 2021 in Review

Marshall Wace North America sold out of Innoviva (INVA) in Q3 2021, closing a stake of 33,585 shares — an estimated $451K sold.

Marshall Wace North America first reported a position in INVA in Q3 2013 and held it in 10 quarters. The position peaked at $10.7M in Q2 2017. 208 funds tracked by Wall St. Rank hold INVA as of Q3 2021.

Marshall Wace North America reported no remaining Innoviva position as of Q3 2021 after selling out during the quarter.
Marshall Wace North America sold 33,585 Innoviva shares in Q3 2021, an estimated $451K.
Marshall Wace North America first reported a position in Innoviva in Q3 2013 and held it in 10 quarters.
Marshall Wace North America's Innoviva position peaked at $10.7M in Q2 2017.
208 funds tracked by Wall St. Rank held Innoviva as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.